Skip to main content
See every side of every news story
Published loading...Updated

The Antisense Drug Bepirovirsen Can Often Cure Hepatitis B.

Guangzhou – A 24-week course of treatment with the antisense oligonucleotide bepirovirsen achieved a functional cure of hepatitis B in one out of every five patients in two Phase 3 trials. This significantly surpassed the efficacy of current therapies using nucleoside or nucleotide analogs (NAs). The manufacturer presented the results in February...

2 Articles

Lean Left

An unpublished drug for hepatitis B allows some patients to stop treatment without showing signs of the dangerous liver virus, which is known as a “functional cure,” researchers reported.

·Los Angeles, United States
Read Full Article

Guangzhou – A 24-week course of treatment with the antisense oligonucleotide bepirovirsen achieved a functional cure of hepatitis B in one out of every five patients in two Phase 3 trials. This significantly surpassed the efficacy of current therapies using nucleoside or nucleotide analogs (NAs). The manufacturer presented the results in February...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news on Tuesday, June 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal